Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

February’s top stories: Thermo Fisher’s $13.6bn deal, Medtronic’s leadless pacemaker

Thermo Fisher Scientific completed its acquisition of Life Technologies, a life sciences company, for approximately $13.6bn, while Medtronic reported the first implant of vitamin-sized leadless pacemaker in US. wraps-up the key headlines from February 2014.

Go Top